2018 - Fellow of the American Association for the Advancement of Science (AAAS)
1999 - Fellow of the American Statistical Association (ASA)
His primary areas of study are Genetics, Cancer, Gene, Mutation and Cancer research. His Disease research extends to the thematically linked field of Genetics. His research in Cancer intersects with topics in Wnt signaling pathway, Oncology and Bioinformatics.
His work on Germline mutation, IDH1 and IDH2 as part of general Mutation research is often related to Isocitrate dehydrogenase, thus linking different fields of science. His work deals with themes such as Missense mutation, Enasidenib, Nonsynonymous substitution, Immunology and Colorectal cancer, which intersect with Cancer research. His study looks at the intersection of Breast cancer and topics like Genetic testing with Family history and Ovarian cancer.
Giovanni Parmigiani mostly deals with Genetics, Internal medicine, Cancer, Oncology and Statistics. His Genetics study is mostly concerned with Gene, Mutation, Genome, Genetic testing and Human genome. His Gene research incorporates themes from Cancer research and Computational biology.
His biological study spans a wide range of topics, including Germline mutation and Bioinformatics. Many of his research projects under Statistics are closely connected to Context with Context, tying the diverse disciplines of science together. The concepts of his Breast cancer study are interwoven with issues in Penetrance and Family history.
Giovanni Parmigiani mainly focuses on Internal medicine, Oncology, Cancer, Multiple myeloma and Computational biology. His study on Oncology also encompasses disciplines like
Giovanni Parmigiani combines subjects such as Unknown Significance, Genetics, Genetic testing and Genetic predisposition with his study of Family history. Many of his studies involve connections with topics such as Cohort and Genetics. His Multiple myeloma research also works with subjects such as
Giovanni Parmigiani mainly investigates Internal medicine, Oncology, Clinical trial, MEDLINE and Meta-analysis. In general Internal medicine study, his work on Disease, Confidence interval, Odds ratio and Cystadenocarcinoma often relates to the realm of Neoplasm Grading, thereby connecting several areas of interest. His Oncology study integrates concerns from other disciplines, such as Concordance, Cancer, Breast cancer and Hazard ratio.
His Cancer research integrates issues from Regulation of gene expression and Gene signature. His studies deal with areas such as Germline, Randomized controlled trial, Surgery and Bioinformatics as well as MEDLINE. His Gene research is multidisciplinary, relying on both Colorectal cancer, Computational biology and Multiple myeloma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
D. Williams Parsons;Siân Jones;Xiaosong Zhang;Jimmy Cheng-Ho Lin.
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Siân Jones;Xiaosong Zhang;D. Williams Parsons;D. Williams Parsons;Jimmy Cheng Ho Lin.
Genomic landscapes of human breast and colorectal cancers
Laura D. Wood;Williams D. Parsons;Sian Jones;Jimmy Lin.
Meta-analysis of BRCA1 and BRCA2 penetrance
Sining Chen;Giovanni Parmigiani.
Journal of Clinical Oncology (2007)
The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia in Adults
M P Weinstein;M L Towns;S M Quartey;S Mirrett.
Clinical Infectious Diseases (1997)
Comparative lesion sequencing provides insights into tumor evolution
Siân Jones;Wei Dong Chen;Wei Dong Chen;Giovanni Parmigiani;Frank Diehl.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Siân Jones;Siân Jones;Ralph H. Hruban;Mihoko Kamiyama;Michael Borges.
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolo Bolli;Hervé Avet-Loiseau;David C. Wedge;Peter Van Loo.
Nature Communications (2014)
Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2
Giovanni Parmigiani;Donald A. Berry;Omar Aguilar.
American Journal of Human Genetics (1998)
The Genetic Landscape of the Childhood Cancer Medulloblastoma
D. Williams Parsons;D. Williams Parsons;Meng Li;Xiaosong Zhang;Siân Jones.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: